Answer
They contain infliximab but differ in presentation, licensed age groups and administration. Switching or changing route should be clinician-led, with the exact brand and batch recorded.
Sources for this answer
- Flixabi 100 mg powder for concentrate for solution for infusion — Current selected SmPCemc · Summary of Product Characteristics
- Remsima 120 mg solution for injection in pre-filled pen — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.